Scarica l'app Stockscreener
0.00
100.00%
-23.80
Dopo l'orario di chiusura:
23.81
23.81
+
Tema Neuroscience And Mental Health Etf Borsa (MNTL) Ultime notizie
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – June 30-July 4, 2025 - Trackinsight
Tema Announces Liquidation of Two ETFs - Business Wire
The Unseen Storm: How Section 899 Could Trigger a Foreign Capital Exodus from U.S. Equities - AInvest
Tema Launches the S&P 500 Historical Weight ETF Strategy (DSPY), First S&P 500 Concentration Innovation Since 2003 - Business Wire
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Hone Your Biotech Allocation With Neuroscience ETF MNTL - ETF Trends
Tema Launches World’s First Electrification ETF ($VOLT) - Business Wire
Where to Invest in Health Trends - Bloomberg.com
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start - Reuters
Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health? - Benzinga
Luma, Yieldstreet Expand Alts Partnership - FA Mag
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
Active ETF Stat Pack - NYSE
This Week in ETFs: Closures Outnumber New ETFs - ETF Trends
Biotechnology ETF List - ETFdb.com
0.73%
0.01%
Capitalizzazione:
|
Volume (24 ore):